hydroxyitraconazole has been researched along with Pulmonary Aspergillosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsumoto, K; Morita, K; Nakamura, Y; Sato, A | 1 |
| Hashinaga, K; Hiramatsu, K; Itoh, H; Kadota, JI; Nonoshita, K; Oyama, N; Sato, Y; Suzuki, Y; Tanaka, R; Umeki, K | 1 |
1 trial(s) available for hydroxyitraconazole and Pulmonary Aspergillosis
| Article | Year |
|---|---|
Sensitive and selective quantification of total and free itraconazole and hydroxyitraconazole in human plasma using ultra-performance liquid chromatography coupled to tandem mass spectrometry.
Topics: Chromatography, High Pressure Liquid; Humans; Itraconazole; Mass Spectrometry; Pulmonary Aspergillosis | 2017 |
1 other study(ies) available for hydroxyitraconazole and Pulmonary Aspergillosis
| Article | Year |
|---|---|
Effective plasma concentrations of itraconazole and its active metabolite for the treatment of pulmonary aspergillosis.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Female; Humans; Itraconazole; Male; Middle Aged; Pulmonary Aspergillosis; Retrospective Studies; ROC Curve; Treatment Outcome | 2020 |